Nephrotic Syndrome Biopsy Indications

Obtain a native kidney biopsy in an adult with nephrotic syndrome when the cause is not evident from the initial evaluation. This remains the default diagnostic pathway because adult nephrotic syndrome includes membranous nephropathy, focal segmental glomerulosclerosis (FSGS), minimal change disease, amyloidosis, fibrillary or immunotactoid glomerulopathy, and Fabry disease, for which histology has distinct therapeutic and prognostic consequences. Kidney International+1Kidney InternationalKDIGO 2021 Clinical Practice Guideline for the Management of ...PubMedRenal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety

Order serum anti-phospholipase A2 receptor antibody (PLA2R-Ab) testing early in a new adult nephrotic presentation. A positive PLA2R-Ab result is sufficiently specific for primary membranous nephropathy that histologic confirmation is not necessary in selected new-onset cases; absence of PLA2R antibodies removes that exception and supports biopsy. PubMedPubMedRenal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety

Do not extrapolate the PLA2R exception to every patient with proteinuria. Biopsy remains appropriate when there is diagnostic uncertainty, including suspected systemic immune disease, paraprotein-related disease, FSGS, minimal change disease, or an atypical clinical course. Kidney manifestations of systemic vasculitis or systemic lupus erythematosus are explicit biopsy indications. PubMedPubMedRenal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety

In children up to age 12 years with a typical idiopathic nephrotic presentation, begin glucocorticoid therapy rather than routinely performing biopsy at onset. Minimal change disease accounts for approximately 90% of idiopathic nephrotic syndrome in the first decade of life, and steroid response is more prognostic than initial histology in this group. BMJ+1BMJMinimal change disease - Symptoms, diagnosis and treatment | BMJ Best Practice USPubMedTo biopsy or not to biopsy a teenager with idiopathic nephrotic syndrome? Biopsy first - PMC

Obtain kidney biopsy for pediatric nephrotic syndrome that fails to respond to initial corticosteroid therapy. Current pediatric guidance uses a 4- to 6-week confirmation period for children with only partial remission at week 4; further glucocorticoid therapy and renin-angiotensin system blockade are assessed during that interval. Steroid-resistant nephrotic syndrome is defined at 6 weeks, with or without a trial of three daily intravenous methylprednisolone doses, and biopsy plus genetic testing should follow. PubMed+1PubMedAligning Practice With Guidelines: A Canadian National Survey and Canadian Society of Nephrology Commentary on the 2025 KDIGO Pediatric Nephrotic Syndrome Recommendations - PMCKidney InternationalExecutive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children - Kidney International

Perform biopsy at initial presentation in children older than 12 years with idiopathic nephrotic syndrome. In this age group, FSGS and other glomerular diseases, including membranous nephropathy and membranoproliferative glomerulopathy, are more prevalent than in younger children. PubMedPubMedTo biopsy or not to biopsy a teenager with idiopathic nephrotic syndrome? Biopsy first - PMC

Consider kidney biopsy during pregnancy for de novo nephrotic syndrome, sudden deterioration in kidney function, or suspected glomerulonephritis when a pathologic diagnosis will change maternal treatment or pregnancy management. In contemporary biopsy cohorts, nephrotic syndrome without acute kidney injury has been a leading indication. Oxford Academic+1Oxford AcademicManaging glomerular disease in pregnancyOxford AcademicKidney biopsy during pregnancy: indications, complications, results ...

When clinical urgency allows, defer biopsy until postpartum because pooled data found complications in 7% of antepartum biopsies versus 1% postpartum biopsies. Most reported complications were minor, including flank pain and macroscopic hematuria; significant complications clustered at 23-26 weeks' gestation. Oxford AcademicOxford AcademicManaging glomerular disease in pregnancy

Do not let concern about biopsy obscure concurrent thrombotic risk assessment. Nephrotic syndrome with serum albumin below 25 g/L increases venous thromboembolism risk in pregnancy, and expert opinion supports thromboprophylaxis throughout pregnancy for severe proteinuria with albumin below 20-25 g/L, with individualized consideration at higher albumin concentrations when additional risk factors such as obesity or immobility are present. Oxford AcademicOxford AcademicManaging glomerular disease in pregnancy

Before scheduling biopsy, define the clinical question in the requisition: primary membranous nephropathy versus another glomerular disease, immune-complex or pauci-immune glomerulonephritis, podocytopathy such as minimal change disease or FSGS, or an infiltrative or hereditary process. This framing determines the value of tissue when serology, systemic disease, or clinical trajectory does not establish the diagnosis. PubMedPubMedRenal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety

Treat biopsy as particularly high value in adult nephrotic syndrome with impaired kidney function, glomerular hematuria, or systemic features because these patterns broaden the differential beyond a primary podocytopathy. Progressive creatinine elevation with acanthocytes or red blood cell casts is a named indication for biopsy. PubMedPubMedRenal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety

A biopsy-sparing approach should remain narrow. PLA2R positivity can support a noninvasive diagnosis of primary membranous nephropathy, but it does not replace tissue evaluation for adults whose presentation suggests another renal process or whose management depends on histologic information. PubMedPubMedRenal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety